The JAK–STAT Pathway in Childhood B-Cell Acute Lymphoblastic Leukemia

Effects of IL-7 and TLSP on the JAK–STAT signaling pathway and the action of selected inhibitors of pathway components: IL-7 leads to the activation of Janus kinases JAK1 and JAK3, as well as STAT1, STAT3, and STAT5, which are translocated to the cell nucleus, regulating gene expression. TSLP, through heterodimerization of IL-7α with CRLF2, activates JAK1 and JAK2, as well as the effector STAT5, which translocate to the cell nucleus and influences gene expression. Fludarabine is an inhibitor of STAT1, while ruxolitinib and fedratinib are JAK2 inhibitors. By preventing the activation of their target molecules, these drugs exert inhibitory effects on the JAK–STAT pathway
The JAK–STAT Pathway in Childhood B-Cell Acute Lymphoblastic Leukemia

Publication

The Role of the JAK–STAT Pathway in Childhood B-Cell Acute Lymphoblastic Leukemia (2024) Karolina Joanna Ziętara, et al. Int J Mol Sci. 2024 Jul;25(13). Figure: F2.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates IL-7Ra IL-7RA ncbigene_synonym IL7R 3575
Homo sapiens Primates IL-7 IL-7 ncbigene_synonym IL7 3574
Homo sapiens Primates IL-7 IL-7 ncbigene_synonym LINC02605 112935892
Homo sapiens Primates JAK1 JAK1 ncbigene_symbol JAK1 3716
Homo sapiens Primates JAK3 JAK3 ncbigene_symbol JAK3 3718
Homo sapiens Primates STAT1 STAT1 ncbigene_symbol STAT1 6772
Homo sapiens Primates STAT3 STAT3 ncbigene_symbol STAT3 6774
Homo sapiens Primates CRLF2 CRLF2 ncbigene_symbol CRLF2 64109
Homo sapiens Primates TSLP TSLP ncbigene_symbol TSLP 85480
Homo sapiens Primates JAK2 JAK2 ncbigene_symbol JAK2 3717

Chemical mentions

Word Match MeSH Name ChEBI
RUXOLITINIB ruxolitinib (3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile chebi:66919

Disease mentions

Word Match MeSH Name DOID